文献速递流行病学与生物统计临床试验与 GCP

考虑短期二分类结局选择治疗组的自适应无缝II/III期随机化检验

Adaptive Seamless Phase II/III Randomization Test Considering Treatment Group Selection Based on Short-Term Binary Outcomes.
PubMed 文献 · Stat Med · 2026-01-01

该研究针对基于短期二分类结局选择治疗组的自适应无缝II/III期设计,提出一种基于随机化分布的检验方法,以恰当考虑II期与III期结局间的相关性。模拟研究显示,该方法改善了因结局相关性导致的保守性,将I类错误率控制在名义水平附近,且在多数情形下把握度高于组合检验法,可提高试验成功概率。

要点

  • 基于短期二分类结局选组的无缝II/III期设计可用随机化检验控制I类错误。
  • 组合检验法在结局相关性降低时过于保守,新方法可改善此问题。
  • 模拟研究中新方法多数情形把握度高于组合检验法。

核心结论

  • 所提出的自适应无缝II/III期随机化检验可基于随机化分布恰当考虑II期二分类结局与III期总生存结局间的相关性。
  • 模拟研究显示该方法改善因结局相关性导致的保守性,将I类错误率控制在名义水平附近,多数情形把握度高于组合检验法,可提高试验成功概率。

研究设计与样本

  • 方法学研究,提出基于随机化分布的自适应无缝II/III期随机化检验,II期为二分类结局,III期为总生存。
  • 通过模拟研究评估所提方法的I类错误率与把握度,并与基于组合检验的方法比较。

主要发现

  • 基于组合检验且考虑短期结局选组的方法倾向于保守,在II期与III期结局相关性降低时对I类错误率控制过严。
  • 模拟研究中,所提方法改善了因结局相关性导致的保守性,将I类错误率控制在名义水平附近。
  • 多数模拟情形下,所提方法的把握度高于基于组合检验的方法。

临床怎么用

  • 在基于短期二分类结局选择治疗组的无缝II/III期设计中,可考虑采用基于随机化分布的检验以恰当处理II期与III期结局相关性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Recently, adaptive seamless phase II/III designs (ASDs) have gained attention because they improve the efficiency of drug development. In an ASD, a phase II trial, which explores the dose-response relationships and identifies treatments for the phase III trial, is combined with a phase III trial, which aims to demonstrate the efficacy and safety of the selected treatment arms in a single trial. This study focused on ASD, which selects treatment groups based on the short-term outcomes observed early in the trial, and involves a confirmatory outcome as the long-term outcome. The method based on the combination test, which considers treatment group selection based on short-term outcomes, tends to be conservative. In other words, it controls the type I error rate more strictly than necessary as the correlation decreases among outcomes in phases II and III. To address this issue, we proposed an adaptive seamless phase II/III randomization test that can appropriately consider the correlation between outcomes based on a randomization distribution, where phase II has a binary outcome and phase III has overall survival. Based on the simulation study, the proposed method improved conservatism owing to the correlation among outcomes and controlled the type I error rate around the nominal level. In addition, the power of this method tended to be higher than that of the method based on the combination test in most scenarios. Overall, the proposed method can increase the probability of trial success compared with conventional phase III designs.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Sato F, Uemura K, Mizusawa J, et al. Adaptive Seamless Phase II/III Randomization Test Considering Treatment Group Selection Based on Short-Term Binary Outcomes. Stat Med. 2026. PMID: 41636418. doi:10.1002/sim.70400

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。